126 related articles for article (PubMed ID: 34139707)
1. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Mustonen H; Koskensalo S; Haglund C; Böckelman C
Oncology; 2021; 99(9):589-600. PubMed ID: 34139707
[TBL] [Abstract][Full Text] [Related]
2. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
[TBL] [Abstract][Full Text] [Related]
3. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome.
Kasurinen A; Hagström J; Laitinen A; Kokkola A; Böckelman C; Haglund C
Sci Rep; 2019 Aug; 9(1):12553. PubMed ID: 31467388
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of tissue TLR2 and TLR4 in colorectal cancer.
Beilmann-Lehtonen I; Böckelman C; Mustonen H; Koskensalo S; Hagström J; Haglund C
Virchows Arch; 2020 Nov; 477(5):705-715. PubMed ID: 32424768
[TBL] [Abstract][Full Text] [Related]
6. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.
Lanki M; Seppänen H; Mustonen H; Hagström J; Haglund C
PLoS One; 2019; 14(7):e0219245. PubMed ID: 31314777
[TBL] [Abstract][Full Text] [Related]
8. The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
Nurmi AM; Hagström J; Mustonen H; Seppänen H; Haglund C
PLoS One; 2022; 17(5):e0267792. PubMed ID: 35536778
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.
Kauppila JH; Mattila AE; Karttunen TJ; Salo T
Br J Cancer; 2013 Feb; 108(3):638-43. PubMed ID: 23287987
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 5 and 8 in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Huhta H; Pohjanen VM; Helminen O
APMIS; 2021 Aug; 129(8):470-479. PubMed ID: 33950532
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
13. Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative.
Cai Z; Xiao J; He X; Ke J; Zou Y; Chen Y; Wu X; Li X; Wang L; Wang J; Lan P; Wu X
Cancer Biomark; 2017; 19(2):161-168. PubMed ID: 28128739
[TBL] [Abstract][Full Text] [Related]
14. TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence.
Haeggblom L; Näsman A; Ramqvist T; Haglund C; Hagström J; Mäkitie A; Dalianis T
Acta Otolaryngol; 2019 Feb; 139(2):206-210. PubMed ID: 30794027
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors 3, 7, 8, and 9 in gastric cancer.
Eskuri M; Kemi N; Helminen O; Huhta H; Kauppila JH
APMIS; 2023 Feb; 131(2):92-99. PubMed ID: 36271773
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
